THE AZELAPRAG CLINICAL TRIALS DIARIES

AMG 986 exposures enhanced nonlinearly with escalating doses; minimal accumulation was observed. In HF with lowered ejection fraction patients, there have been numerical boosts in per cent changes from baseline in LV ejection fraction and stroke volume by volumetric assessment with AMG 986 vs placebo (stroke volume boost not recapitulated by Dopple